期刊文献+

伊曲康唑注射液和口服液对ICU深部真菌感染的序贯治疗 被引量:5

下载PDF
导出
摘要 目的评价伊曲康唑注射液与口服液的序贯疗法对深部真菌感染的疗效与安全。方法伊曲康唑注射液200mg,每12小时1次,连用2d,继200mg,1次/d,连用5d;再改用伊曲康唑口服液200mg,2次/d,连用14d。治疗深部真菌感染18例,确诊2例,拟诊11例,经验治疗5例。结果确诊和拟诊的13例患者,综合疗效总有效率76.2%,真菌清除率84.6%。总副作用发生率27.8%,但均轻度,不影响治疗。结论伊曲康唑静脉与口服的序贯疗法治疗深部真菌感染有效安全,可作为第一线用药。
出处 《广东医学》 CAS CSCD 北大核心 2007年第4期645-647,共3页 Guangdong Medical Journal
  • 相关文献

参考文献7

  • 1ZAAS A K,ALEXANDER B D.Echinocandins:role in antifungaltherapy,2005[J].Expert Opin Pharmacother,2005,6 (10):1 657 -1 668.
  • 2KAREL D B,JEF V G.Pharmacology of itraconazole[J].Drugs,2001,61 (Suppl 1):S27-S37.
  • 3BOOGAERTS M,WINSTON D J,BOW E J,et al.Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy[J].Ann Intern Med,2001,135(6):412-422.
  • 4WINSTON D J,MAZIARZ R T,CHANDRASEKAR P H,et al.Intravenous and oral itraconazole versus intravenous abd oral fluconazole for long-term antifungal prophylaxis in allogoneic hematopoietic stem-cell transplant recipients,A multicenter,randomized trial[J].Ann Intern Med,2003,138(9):705 -713.
  • 5HAROUSSEAU J L,DEKKER A W,STAMATOULLAS-BASTARD A,et al.Itraconazole oral solution for primary prophylaxis of fungsl infections in patients with hematologic malignancy and profound neutropenia:a randomized,double-blind,double -placebo,multicenter trial comparing itraconazole and amphotericin B[J].Antimicrob Agents Chemother,2000,44(7):1 887 -1 893.
  • 6REX J H,WALSH T J,SOBEL J D,et al.Practice guideline for the treatment of candidiasis[J].Clin Infect Dis,2000,30(4):662-678.
  • 7HAEMATOL A.Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis[J].Acta Haematol,2003,109(3):111-118.

同被引文献46

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部